MCID: HPT007
MIFTS: 56

Hepatitis E

Categories: Cancer diseases, Endocrine diseases, Gastrointestinal diseases, Genetic diseases, Immune diseases, Infectious diseases, Liver diseases, Rare diseases, Skin diseases

Aliases & Classifications for Hepatitis E

MalaCards integrated aliases for Hepatitis E:

Name: Hepatitis E 12 77 54 56 45 15 17 74

Classifications:



External Ids:

Disease Ontology 12 DOID:4411
MeSH 45 D016751
UMLS 74 C0085293

Summaries for Hepatitis E

Disease Ontology : 12 A viral infectious disease that results in inflammation located in liver, has material basis in Hepatitis E virus, which is transmitted by ingestion of contaminated food. The infection has symptom fever, has symptom fatigue, has symptom loss of appetite, has symptom nausea, has symptom vomiting, has symptom abdominal pain, has symptom clay-colored bowel movements, has symptom dark urine, has symptom joint pain, and has symptom jaundice.

MalaCards based summary : Hepatitis E is related to infantile liver failure syndrome 1 and acute liver failure, and has symptoms including fever, vomiting and fatigue. An important gene associated with Hepatitis E is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways/superpathways are NF-kappaB Signaling and Colorectal Cancer Metastasis. The drugs Aluminum hydroxide and Aluminum sulfate have been mentioned in the context of this disorder. Affiliated tissues include liver, kidney and testes, and related phenotypes are endocrine/exocrine gland and neoplasm

Wikipedia : 77 Hepatitis E is inflammation of the liver caused by infection with the hepatitis E virus. It is one of... more...

Related Diseases for Hepatitis E

Diseases in the Hepatitis family:

Hepatitis C Virus Autoimmune Hepatitis
Hepatitis B Hepatitis a
Hepatitis C Viral Hepatitis
Hepatitis D Hepatitis E

Diseases related to Hepatitis E via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 218)
# Related Disease Score Top Affiliating Genes
1 infantile liver failure syndrome 1 30.9 ALB F2 GPT
2 acute liver failure 30.8 ALB F2 GPT
3 viral hepatitis 30.5 ALB F2 GPT TNF
4 hepatitis a 30.2 ALB F2 GPT IFNG TNF
5 liver disease 30.2 ALB F2 GPT TNF
6 hepatitis c 30.1 GPT IFNG TLR3 TNF
7 hepatitis b 30.0 ALB F2 GPT IFNG TNF
8 hepatitis d 29.8 F2 GPT
9 hepatic coma 29.6 ALB F2 GPT
10 cholecystitis 29.6 ALB F2 GPT
11 typhoid fever 29.5 ALB F2 IFNG TNF
12 leptospirosis 29.5 F2 IFNG TNF
13 alcoholic hepatitis 29.5 ALB F2 GPT TNF
14 meningitis 29.4 ALB IFNG TNF
15 hepatic encephalopathy 29.2 ALB F2 GPT TNF
16 cholangitis 29.2 ALB F2 GPT TNF
17 human immunodeficiency virus type 1 29.2 IFNG TLR3 TNF TSG101
18 common variable immunodeficiency 28.8 CD40LG IFNG TNF
19 schistosomiasis 28.7 ALB CD40LG F2 IFNG TNF
20 hepatitis 11.3
21 hepatoportal sclerosis 10.3 F2 GPT
22 antipyrine metabolism 10.3 ALB F2
23 non-a-e hepatitis 10.3 ALB F2
24 epstein-barr virus hepatitis 10.3 ALB F2
25 variola major 10.3 IFNG TLR3
26 abdominal tuberculosis 10.3 ALB F2
27 guillain-barre syndrome 10.2
28 marburg hemorrhagic fever 10.2 F2 TNF
29 staphylococcal toxic shock syndrome 10.2 IFNG TNF
30 adult dermatomyositis 10.2 GPT TNF
31 autoimmune myocarditis 10.2 IFNG TNF
32 trichosporonosis 10.2 IFNG TNF
33 hypertensive nephropathy 10.2 ALB AMBP
34 chronic beryllium disease 10.2 IFNG TNF
35 opisthorchiasis 10.2 GPT TNF
36 scleritis 10.2 IFNG TNF
37 miliary tuberculosis 10.2 IFNG TNF
38 african tick-bite fever 10.2 CD40LG IFNG
39 sporotrichosis 10.2 CD40LG IFNG
40 mucocutaneous leishmaniasis 10.2 TLR3 TNF
41 clonorchiasis 10.2 IFNG TNF
42 burns 10.2 ALB TNF
43 microscopic colitis 10.2 IFNG TNF
44 vascular hemostatic disease 10.2 F2 TNF
45 splenic disease 10.2 ALB F2
46 crohn's colitis 10.2 IFNG TNF
47 amyotrophic neuralgia 10.2
48 hepatic tuberculosis 10.1 ALB F2 GPT
49 kwashiorkor 10.1 ALB F2 GPT
50 choledocholithiasis 10.1 ALB F2 GPT

Graphical network of the top 20 diseases related to Hepatitis E:



Diseases related to Hepatitis E

Symptoms & Phenotypes for Hepatitis E

Symptoms:

12
  • fever
  • vomiting
  • fatigue
  • abdominal pain
  • jaundice
  • nausea
  • joint pain
  • loss of appetite
  • clay-colored bowel movements
  • dark urine

MGI Mouse Phenotypes related to Hepatitis E:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.76 ALB AMBP CD40LG FGB IFNG TLR3
2 neoplasm MP:0002006 9.35 ALB IFNG TLR3 TNF TSG101
3 reproductive system MP:0005389 9.17 AMBP CD40LG F2 FGB IFNG TLR3

Drugs & Therapeutics for Hepatitis E

Drugs for Hepatitis E (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3,Phase 1 21645-51-2
2
Aluminum sulfate Approved Phase 4,Phase 3 10043-01-3
3
Ribavirin Approved Phase 4,Phase 2 36791-04-5 37542
4 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
5 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
6 Antimetabolites Phase 4,Phase 2
7 Anti-Infective Agents Phase 4,Phase 2,Not Applicable
8 Antiviral Agents Phase 4,Phase 2,Not Applicable
9
Milk thistle Approved, Experimental, Investigational Phase 2, Phase 3 65666-07-1
10
Nicotinamide Approved, Investigational Phase 2, Phase 3,Phase 3 98-92-0 936
11
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-30-3 6037
12
Thiamine Approved, Investigational, Nutraceutical, Vet_approved Phase 2, Phase 3,Phase 3 59-43-8, 70-16-6 1130
13
Niacin Approved, Investigational, Nutraceutical Phase 2, Phase 3,Phase 3 59-67-6 938
14
Riboflavin Approved, Investigational, Nutraceutical, Vet_approved Phase 2, Phase 3 83-88-5 493570
15 Vitamin B9 Phase 2, Phase 3
16 Folate Phase 2, Phase 3
17 Micronutrients Phase 2, Phase 3
18 Thiamin Phase 2, Phase 3
19 Protective Agents Phase 2, Phase 3
20 Vitamin B3 Phase 2, Phase 3
21 silymarin Phase 2, Phase 3
22 Antioxidants Phase 2, Phase 3
23 Nutrients Phase 2, Phase 3
24 Vitamin B Complex Phase 2, Phase 3
25 Vitamin B2 Phase 2, Phase 3
26 Nicotinic Acids Phase 2, Phase 3
27 Trace Elements Phase 2, Phase 3
28 Vitamins Phase 2, Phase 3
29
Sofosbuvir Approved Phase 2 1190307-88-0 45375808
30
Entecavir Approved, Investigational Phase 2,Not Applicable 142217-69-4 153941
31
Peginterferon alfa-2a Approved, Investigational Phase 2 198153-51-4 5360545
32 Liver Extracts Phase 2,Phase 1
33 interferons Phase 2
34
Tacrolimus Approved, Investigational Phase 1 104987-11-3 445643 439492 6473866
35
Basiliximab Approved, Investigational Phase 1 152923-56-3, 179045-86-4
36 Immunosuppressive Agents Phase 1
37 Pharmaceutical Solutions Phase 1
38
Permethrin Approved, Investigational Not Applicable 52645-53-1 40326
39 Antibodies
40 Immunoglobulins

Interventional clinical trials:

(show all 33)
# Name Status NCT ID Phase Drugs
1 A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) Completed NCT03168412 Phase 4
2 A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) Completed NCT02964910 Phase 4
3 A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) Completed NCT02417597 Phase 4
4 Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®) Completed NCT02189603 Phase 4
5 A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) Completed NCT02584543 Phase 4
6 Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh. Active, not recruiting NCT02759991 Phase 4 Hecolin;Hepa-B
7 Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. Terminated NCT02558114 Phase 4 Ribavirin
8 A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) Withdrawn NCT03365921 Phase 4
9 Clinical Trial of Recombinant Hepatitis E Vaccine Unknown status NCT01014845 Phase 3
10 Field Trial of Maternal Influenza Immunization in Asia Unknown status NCT01034254 Phase 3
11 Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine Active, not recruiting NCT01735006 Phase 3
12 Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis Terminated NCT00755950 Phase 2, Phase 3
13 A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus Unknown status NCT01698723 Phase 2 Ribavirin;Placebo
14 HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) Completed NCT03282474 Phase 2 Sofosbuvir
15 Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen Completed NCT01204762 Phase 2 pegIFN;pegIFNα-2a;PegIFN lambda;Entecavir
16 Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine Active, not recruiting NCT02710851 Phase 2
17 A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. Withdrawn NCT00287469 Phase 2
18 A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults Completed NCT02603055 Phase 1
19 Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation Recruiting NCT02957552 Phase 1
20 Safety Study of Hepatitis E Vaccine (HEV239) in Healthy US Adult Population Not yet recruiting NCT03827395 Phase 1
21 The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors Unknown status NCT02419625 Not Applicable
22 Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis Patients Unknown status NCT02645955
23 Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille. Unknown status NCT02819128 Not Applicable
24 Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb) Completed NCT02847507
25 Seroprevalence of Hepatitis E in People With an Organ Transplant Completed NCT02190253
26 Role of Cytokines in Hepatitis E Virus Infection During Pregnancy Completed NCT01062321
27 Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection Completed NCT01090232 Not Applicable
28 Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy Completed NCT01858519
29 Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E Completed NCT01813487 Not Applicable HBsAg vaccine with Entecavir
30 Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study Recruiting NCT02809885 Not Applicable
31 Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms. Recruiting NCT03524014
32 Seroprevalence Hepatitis E Infection in Healthy Blood Donors Recruiting NCT03601221
33 HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver Not yet recruiting NCT03488589

Search NIH Clinical Center for Hepatitis E

Cochrane evidence based reviews: hepatitis e

Genetic Tests for Hepatitis E

Anatomical Context for Hepatitis E

MalaCards organs/tissues related to Hepatitis E:

42
Liver, Kidney, Testes, T Cells, Heart, B Cells, Brain

The Foundational Model of Anatomy Ontology organs/tissues related to Hepatitis E:

20
Liver

Publications for Hepatitis E

Articles related to Hepatitis E:

(show top 50) (show all 3033)
# Title Authors Year
1
Case Report: Acute Hepatitis E in a Pediatric Traveler Presenting with Features of Autoimmune Hepatitis: A Diagnostic and Therapeutic Challenge. ( 30350777 )
2019
2
Hepatitis E virus as an agent of hepatocellular carcinoma. ( 30634042 )
2019
3
Guillain-Barré syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review. ( 30881857 )
2019
4
Identification of a zoonotic genotype 3 hepatitis E subtype in wildlife in north-eastern Italy. ( 30876888 )
2019
5
Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series. ( 30879545 )
2019
6
Prevalence of hepatitis E virus infection among people and swine in mainland China: A systematic review and meta-analysis. ( 30884147 )
2019
7
Antiviral candidates for treating hepatitis E virus infection. ( 30885901 )
2019
8
Genetic diversity of hepatitis E virus (HEV) strains derived from humans, swine and wild boars in Croatia from 2010 to 2017. ( 30890143 )
2019
9
Chicken organic anion transporting polypeptide 1A2, a novel avian hepatitis E virus (HEV) ORF2-interacting protein, is involved in avian HEV infection. ( 30894478 )
2019
10
Acute Hepatitis E is an Underreported Cause of Severe Acute Liver Injury. ( 30902228 )
2019
11
Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study. ( 30903372 )
2019
12
A signal amplification system on a lateral flow immunoassay detecting for hepatitis e antigen in human blood samples. ( 30851129 )
2019
13
Antibody and Memory B Cell Responses in Hepatitis E Recovered Individuals, 1-30 Years Post Hepatitis E Virus Infection. ( 30858463 )
2019
14
Should 12 or 24 weeks post-ribavirin follow-up be considered to define sustained virological response in transplant-patients treated for chronic hepatitis E virus infection? ( 30860299 )
2019
15
HEVnet: a One Health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis E virus molecular typing, characterisation and epidemiological investigations. ( 30862334 )
2019
16
Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017. ( 30862337 )
2019
17
Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening. ( 30862338 )
2019
18
High prevalence of hepatitis E virus infection among domestic pigs in Ibaraki Prefecture, Japan. ( 30866949 )
2019
19
Spicatoside A derived from Liriope platyphylla root ethanol extract inhibits hepatitis E virus genotype 3 replication in vitro. ( 30867434 )
2019
20
Application of Hepatitis E Virus-Related Markers on Samples from a Developing Country. ( 30868849 )
2019
21
Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017. ( 30869027 )
2019
22
Hepatitis E virus (HEV)-The Future. ( 30871152 )
2019
23
Tracing Hepatitis E Virus in Pigs From Birth to Slaughter. ( 30873419 )
2019
24
Hepatitis E virus in sheep in Italy. ( 30811818 )
2019
25
Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study. ( 30813268 )
2019
26
Hepatitis E virus prevalence in Egyptian children with transfusion-dependent thalassemia. ( 30826379 )
2019
27
Current status of hepatitis E virus infection at a rhesus monkey farm in China. ( 30827396 )
2019
28
Leptospira spp., rotavirus, norovirus, and hepatitis E virus surveillance in a wild invasive golden-headed lion tamarin (Leontopithecus chrysomelas; Kuhl, 1820) population from an urban park in Niterói, Rio de Janeiro, Brazil. ( 30828830 )
2019
29
Hepatitis E Virus Infection in Bulgaria: A Brief Analysis of the Situation in the Country. ( 30834019 )
2019
30
Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C. ( 30836071 )
2019
31
Identification of Hepatitis E Virus Subtype 4f in Blood Donors Shanghai, China. ( 30836112 )
2019
32
Hepatitis E virus strains infecting Swedish domestic pigs are unique for each pig farm and remain in the farm for at least two years. ( 30784199 )
2019
33
Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018. ( 30789146 )
2019
34
A guide to the management of hepatitis E infection during pregnancy. ( 30791760 )
2019
35
Response to: 'Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn's disease'. ( 30800323 )
2019
36
Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A. ( 30802475 )
2019
37
Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland. ( 30803864 )
2019
38
Detection of Hepatitis E Virus in Raw Pork and Pig Viscera As Food in Hebei Province of China. ( 30807231 )
2019
39
Clinical presentations of Hepatitis E: A clinical review with representative case histories. ( 30808575 )
2019
40
Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus. ( 30733562 )
2019
41
Serological evidence of hepatitis E virus and influenza A virus infection in farmed wild boars in China. ( 30738024 )
2019
42
A case-control study into risk factors for acute hepatitis E in the Netherlands, 2015-2017. ( 30738918 )
2019
43
Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. ( 30760069 )
2019
44
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study. ( 30768677 )
2019
45
Transmission of A Novel Genotype Hepatitis E Virus from Bactrian Camels to Cynomolgus Macaques. ( 30700602 )
2019
46
Near-Complete Genome Sequence of a Human Pegivirus Variant Isolated from a Hepatitis E Virus-Infected Patient. ( 30701229 )
2019
47
Probable transmission of hepatitis E virus (HEV) via transfusion in the United States. ( 30702157 )
2019
48
Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1-mediated translation inhibition. ( 30702423 )
2019
49
Correction to: Prevalence and phylogenetic analysis of hepatitis E virus in pigs, wild boars, roe deer, red deer and moose in Lithuania. ( 30704501 )
2019
50
Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial. ( 30711651 )
2019

Variations for Hepatitis E

Expression for Hepatitis E

Search GEO for disease gene expression data for Hepatitis E.

Pathways for Hepatitis E

GO Terms for Hepatitis E

Cellular components related to Hepatitis E according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.91 ALB AMBP CD40LG F2 FGB IFNG
2 extracellular exosome GO:0070062 9.87 ALB AMBP F2 FGB GPT TSG101
3 external side of plasma membrane GO:0009897 9.56 CD40LG F2 FGB TNF
4 cell surface GO:0009986 9.55 AMBP CD40LG FGB TLR3 TNF
5 extracellular space GO:0005615 9.28 ALB AMBP CD40LG F2 FGB GPT
6 blood microparticle GO:0072562 9.26 ALB AMBP F2 FGB

Biological processes related to Hepatitis E according to GeneCards Suite gene sharing:

(show all 24)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.91 CD40LG F2 IFNG TNF
2 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.77 CD40LG TLR3 TNF
3 response to virus GO:0009615 9.69 IFNG TLR3 TNF
4 platelet activation GO:0030168 9.67 CD40LG F2 FGB
5 positive regulation of interleukin-8 production GO:0032757 9.62 TLR3 TNF
6 positive regulation of protein complex assembly GO:0031334 9.61 IFNG TNF
7 fibrinolysis GO:0042730 9.6 F2 FGB
8 positive regulation of osteoclast differentiation GO:0045672 9.58 IFNG TNF
9 viral budding via host ESCRT complex GO:0039702 9.58 TSG101 VPS4A
10 positive regulation of chemokine production GO:0032722 9.57 TLR3 TNF
11 microglial cell activation GO:0001774 9.56 TLR3 TNF
12 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.55 IFNG TNF
13 ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway GO:0043162 9.54 TSG101 VPS4A
14 extrinsic apoptotic signaling pathway GO:0097191 9.54 IFNG TLR3 TNF
15 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.52 FGB TNF
16 positive regulation of viral release from host cell GO:1902188 9.48 TSG101 VPS4A
17 positive regulation of chemokine biosynthetic process GO:0045080 9.46 TLR3 TNF
18 necroptotic signaling pathway GO:0097527 9.43 TLR3 TNF
19 regulation of immunoglobulin secretion GO:0051023 9.4 CD40LG TNF
20 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.32 IFNG TNF
21 positive regulation of viral budding via host ESCRT complex GO:1903774 9.26 TSG101 VPS4A
22 positive regulation of vitamin D biosynthetic process GO:0060557 9.16 IFNG TNF
23 positive regulation of interleukin-12 production GO:0032735 9.13 CD40LG IFNG TLR3
24 positive regulation of exosomal secretion GO:1903543 8.8 IFNG TSG101 VPS4A

Sources for Hepatitis E

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....